Accelerating Innovation to Market: How GMDx Genomics is Partnering with Vibrant IP to Unlock the Value of Its Patent Portfolio

Updated: Oct 9
Customer Spotlight | Vibrant IP
For life sciences innovators, a strong patent portfolio can be one of the most valuable assets a
company holds. Turning that portfolio into a real transaction, whether a sale, license, or
strategic partnership, takes more than a listing. It takes preparation, positioning, and access to
the right decision makers at the right time.
GMDx Genomics is working with Vibrant IP to do exactly that: monetize its IP. With positive
initial interest in its offering, Bernie Romanin, CEO and Director of GMDx Genomics, shared
why the company chose Vibrant IP.
“What stands out is the depth of the team. You're not handing your IP to a single
broker. You're getting a full group of experienced professionals who understand the
science, the patents, and the business case, and who know how to get in front of
the people who actually make decisions.”
— Bernie Romanin, CEO and Director, GMDx Genomics
A Trusted Recommendation from the Capital Side
Matthew Kilpatrick, Founder and Strategic Corporate Adviser at GMDx Genomics, brings a
capital partner's view to the relationship. Having worked with a range of technology startups, he
has seen firsthand how difficult it can be for young companies to monetize their patented
technologies. It is one key reason why he recommended Vibrant IP to GMDx.
“In my experience with early-stage companies, the patents are often where much of
the value sits, but most founders don't have the time, networks, or specialist
knowledge to realize it.”
— Matthew Kilpatrick, Founder and Strategic Corporate Adviser, GMDx Genomics
Choosing a Specialist for a Life Sciences Estate
GMDx Genomics holds a patent estate in precision oncology, built on methods that attribute the
mutations in a tumor to the enzymes that caused them. For an estate of that kind, the company
wanted a partner whose experience was in medical, pharmaceutical, and biotech transactions
rather than in patents generally.
“In life sciences, credibility with the buyer matters enormously. We wanted a partner
whose track record and relationships were in pharma, biotech, and diagnostics, and
whose process would stand up to the way those organizations evaluate technology.
That focus was the reason we engaged Vibrant IP.”
— Bernie Romanin
Focus and Direction in Reaching the Market
For Bernie Romanin, the value of Vibrant IP's approach has been its direction: outreach aimed
at the organizations where the technology is most relevant, run through a structured process.
“Vibrant IP moved quickly, and more importantly, they moved in the right direction.
Their outreach is focused on the companies where our technology is most relevant,
and it is aimed at the people in those companies who make decisions.”
— Bernie Romanin
“The process is structured the way a serious acquirer expects: public materials first,
then a mutual NDA, then the confidential data room and direct access to our
scientific team. Having that in place before outreach starts is what makes the
conversations productive.”
— Bernie Romanin
A Comprehensive, Team-Based Approach
Behind the GMDx engagement is a dedicated team of Vibrant IP professionals, each
contributing to a different stage of the process:
• IP readiness and preparation: reviewing and positioning the portfolio so it is ready to be
offered with clarity and credibility.
• Marketing the IP: developing materials that communicate the technology's value to
technical and business audiences alike.
• Data room preparation: organizing the documentation serious buyers and licensees
expect during evaluation and diligence.
• Buyer and licensee identification: mapping the market to find the organizations with the
strongest strategic fit.
• Qualification and outreach: vetting prospective counterparties and engaging them
directly, often at the executive level.
• Ongoing transaction support: providing a range of additional services as opportunities
develop.
This end-to-end model makes Vibrant IP's offering one of the most comprehensive in the patent
brokering marketplace.
“The model is genuinely full-service, from readiness through the data room to
qualification and outreach. For a company of our size, having one team carry the
whole process matters.”
— Bernie Romanin
Deep Roots in Medical, Pharmaceutical, and Biotech
Vibrant IP has long been a leader in patent transactions across the medical, pharmaceutical,
and biotech sectors. That history gives the team a clear understanding of how these industries
evaluate technology, and the relationships to reach leaders across them.
Looking Ahead
GMDx Genomics is running a structured sale process for its patent estate through Vibrant IP,
and will evaluate what the process produces alongside its corporate objectives.
“Vibrant IP gives a company of our size a route to the acquirers that matter for this
technology, run as a structured process. We will consider what it produces carefully
as we continue to execute on our strategy.”
— Bernie Romanin
About GMDx Genomics
GMDx Genomics (GMDx Group Ltd) is a Melbourne, Australia based precision-oncology
company. Its patented codon-context methods attribute somatic mutations in a tumor to the
deaminase enzymes that caused them, and its Immune Fitness Profile (IFP) uses those
signatures to predict response to cancer immunotherapy, with validation in four non-small cell
lung cancer studies. The patent estate comprises 45 active patent assets across 11 national
jurisdictions plus European Patent coverage, with priority from November 2012, supported by
the CRIS (Codon Reference Information System) analytical platform. GMDx is offering the
estate to a strategic acquirer through Vibrant IP. Company contact: Bernie Romanin, CEO.
Inquiries about the patent estate: Vibrant IP, LLC, reference VIP-3622.
About Vibrant IP
Vibrant IP helps innovators, startups, and established companies realize the value of their
patented technologies through transaction readiness, marketing, data room preparation, and
targeted buyer and licensee outreach. With deep expertise in medical, pharmaceutical, and
biotech technologies, Vibrant IP connects patent owners with executive decision makers across
industries.
Learn more at vibrantip.com




Comments